Fifteen-year outcomes of external radiation with or without 6 months of neoadjuvant deprivation therapy for intermediate risk prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: A systematic review and meta-analysis. This ...
TCT 752: Combined valvular and subvalvular intervention with Innovalve TMVR facilitates reverse remodeling and improves left ventricular ejection fraction in patients with severe chronic mitral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results